Intuniv Uses

Links shared publicly online about this topic

Intuniv for ADHD: Metabolic Challenges

corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of IntunivView full resource at corepsychblog.com

  • View Related
  • Share

Most Recently Shared on February 1, 2010 at 11:01 am By:

drcharlesparkerEducator, Writer, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician

New post: Intuniv for ADHD: Metabolic Challenges http://goo.gl/fb/oOAJ

2 years ago...

Intuniv for ADHD: Metabolic Challenges

corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of IntunivView full resource at corepsychblog.com

  • View Related
  • Share

Most Recently Shared on February 4, 2010 at 9:50 am By:

drcharlesparkerEducator, Writer, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician

Many links on info re: Intuniv for ADHD: Metabolic Challenges http://bit.ly/d9jFyi including addiction, dosing, tenex #ADHD #neuroscience

2 years ago...

Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants

rttnews.com — “Shire plc (SHP.L, SHPGY) said that the US FDA approved the use of once-daily INTUNIV Extended-Release Tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder, also known as ADHD, in children and adolescents ages 6 to 17 as part of a total treatment program.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on February 28, 2011 at 3:18 pm By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Shire: FDA Oks INTUNIV ER Tablets For Use As Adjunctive Therapy To Stimulants http://bit.ly/dUc4ur #ADHD

1 year ago...

Shire ADHD treatment Intuniv approved for use with a stimulant | Markets | Market News | Canadian Business Online

canadianbusiness.com — “Irish drugmaker Shire Plc. said Monday the U.S. Food and Drug Administration approved the use of attView full resource at canadianbusiness.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 7:04 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Shire ADHD treatment Intuniv approved for use with a stimulant http://bit.ly/hlBbwS #ADHD

1 year ago...

Intuniv for ADHD: Metabolic Challenges | CorePsych Blog

corepsychblog.com — “This post is the fifth, with four others, documenting Intuniv Overview, Dosing Details, Drug Interactions and Addiction Indications. Please review all of these posts for more informed use of IntunivView full resource at corepsychblog.com

  • View Related
  • Share

Most Recently Shared on October 31, 2010 at 5:22 pm By:

drcharlesparkerEducator, Writer, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician

Intuniv for ADHD: Metabolic Challenges - 63 Comments on dosing strategies http://bit.ly/ctGNUW #ADHD #medications #Medications

2 years ago...

Intuniv gains indication as adjunctive therapy in ADHD - ONA

oncologynurseadvisor.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on February 28, 2011 at 3:40 pm By:

Intuniv gains indication as adjunctive therapy in ADHD - MPR

empr.com — “Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6--17 years as part of a total treatment program.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on February 28, 2011 at 3:44 pm By:

eMPR MPR Medical Publisher

MPR News: Intuniv gains indication as adjunctive therapy in ADHD: Shire announced that the FDA has approved Intu... http://bit.ly/eyR7Gr

1 year ago...

FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets For Use As Adjunctive Therapy To Stimulants For The Treatment Of ADHD

medicalnewstoday.com — “Shire plc, (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV® (guView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 8:33 pm By:

Health_CK Catherine K Health Advocate

FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets For Use As Adjunctive Therapy To Stimulants F... http://bit.ly/ePyJtA #adhd

1 year ago...

Google Sidewiki entry about Intuniv for ADHD: Understanding Tenex, Guanfacine and Alpha 2

google.com — “Some very interesting comments and updates are following the ADHD crew here - some useful points on Intuniv as well as the larger question of specific testing.View full resource at google.com

  • View Related
  • Share

Most Recently Shared on January 17, 2010 at 11:15 pm By:

drcharlesparkerEducator, Writer, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician

Over 100 Comments-Sidewiki entry on "Intuniv for ADHD: Understanding Tenex, Guanfacine and Alpha 2" http://bit.ly/78jSJq

2 years ago...

PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents

pharmalive.com — “PharmaLive: FDA Approves Intuniv (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and AdolescentsView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on February 28, 2011 at 7:27 pm By:

pharmalive PharmaLive Pharma and Health News

Daily Advantage - FDA OKs Wider Intuniv Use - http://tinyurl.com/4on7zsc

1 year ago...

Shire Announces FDA Approval of Once-Daily Intuniv (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17

drugs.com — “Intuniv (guanfacine) is used to treat Attention-Deficit/Hyperactivity Disorder in children and adolescents aged 6 to 17 years. Includes Intuniv side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 4, 2009 at 12:32 am By:

drugscom Drugs.com Health Site

FDA Approves Intuniv (guanfacine) for the Treatment of ADHD in Children and Adolescents - http://bit.ly/EObbC

3 years ago...

FDA approves guanfacine ER tablets to treat ADHD in children, teens - - Drug Topics

drugtopics.modernmedicine.com — “FDA approved the use of once-daily guanfacine (Intuniv, Shire) extended-release tablets as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder in children and adolescents aged 6 to 17 years as part of a total treatment program.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on March 2, 2011 at 7:52 pm By:

Health_CK Catherine K Health Advocate

FDA approves guanfacine ER tablets to treat ADHD in children, teens: FDA approved the use of once-daily gu... http://bit.ly/hRwbtM #adhd

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • drcharlesparkerEducatorWriter, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." />

    Dr Charles Parker

    Dr. Parker is an EducatorWriter, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally.

    View Profile

  • drcharlesparkerEducatorWriter, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." />

    Dr Charles Parker

    Dr. Parker is an EducatorWriter, NeuroscientistChild and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally.

    View Profile

  • PeterBrownPsy

    Peter H Brown

    Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390